Site-directed mutation and prokaryotic expression vector construction and fusion protein expression of human beta-defensin 3
Han Yue
Abstract
Han Yue
Abstract
AIM: Site-directed mutation of human β-defensin-3 gene was conducted by PCR protocol and the mutated gene was subcloned into prokaryotic expression vector. METHODS: A two-step polymerase chain reaction (PCR) was used for the site-directed mutagenesis. Two sets of primers (P1, P2, P3, P4) were designed according to human β-defensin-3 gene sequence and the mismatch was introduced into P2 and P3. Mutagenesis was performed in a two-step PCR and the amplified fragments from the second PCR, which contain the mutation site, were subcloned into the vector pGEX-4T-1. Recombinant pGEX-4T-1 vectors were transformed into compotent cell BL21. Restriction analysis and PCR were performed to identify the recombinant plasmids containing the DNA fragment of interest, followed by sequencing. RESULTS: We obtained a 138 bp DNA fragment which was identical to human β-defensin-3 mutant. SDS-PAGE profile showed a clear protein band with a relative molecular weight of 31 000. CONCLUSION: Human β-defensin-3 gene is successfully mutated and expressed, which will help the preparation of antimicrobial peptide.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: Site-directed mutation of human β-defensin-3 gene was conducted by PCR protocol and the mutated gene was subcloned into prokaryotic expression vector. METHODS: A two-step polymerase chain reaction (PCR) was used for the site-directed mutagenesis. Two sets of primers (P1, P2, P3, P4) were designed according to human β-defensin-3 gene sequence and the mismatch was introduced into P2 and P3. Mutagenesis was performed in a two-step PCR and the amplified fragments from the second PCR, which contain the mutation site, were subcloned into the vector pGEX-4T-1. Recombinant pGEX-4T-1 vectors were transformed into compotent cell BL21. Restriction analysis and PCR were performed to identify the recombinant plasmids containing the DNA fragment of interest, followed by sequencing. RESULTS: We obtained a 138 bp DNA fragment which was identical to human β-defensin-3 mutant. SDS-PAGE profile showed a clear protein band with a relative molecular weight of 31 000. CONCLUSION: Human β-defensin-3 gene is successfully mutated and expressed, which will help the preparation of antimicrobial peptide.
Key concepts: Molecular biology, Biology, Recombinant DNA, Gene, Expression vector, Plasmid, Mutagenesis, Mutant